Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients.
about
Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophreniaReal-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits.Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical AntipsychoticsHealth care resource utilization and costs of California Medicaid patients with schizophrenia treated with paliperidone palmitate once monthly or atypical oral antipsychotic treatment.Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting.Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics.
P2860
Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Impact of paliperidone palmita ...... mes in schizophrenia patients.
@en
Impact of paliperidone palmita ...... mes in schizophrenia patients.
@nl
type
label
Impact of paliperidone palmita ...... mes in schizophrenia patients.
@en
Impact of paliperidone palmita ...... mes in schizophrenia patients.
@nl
prefLabel
Impact of paliperidone palmita ...... mes in schizophrenia patients.
@en
Impact of paliperidone palmita ...... mes in schizophrenia patients.
@nl
P2093
P2860
P356
P1476
Impact of paliperidone palmita ...... mes in schizophrenia patients.
@en
P2093
Erik Muser
Jacqueline Pesa
John Fastenau
Marie-Hélène Lafeuille
Mei Sheng Duh
Patrick Lefebvre
Yongling Xiao
P2860
P304
P356
10.2217/CER.15.34
P577
2015-07-14T00:00:00Z